跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,765 条关于
“amyloid-beta protofibrils”
全部
9,765
临床试验
6,912
药物
1,097
机构
26
资讯
1,730
9个月前
LEQEMBI Shows Measurable Target Engagement with Alzheimer's Protofibrils in Cerebrospinal Fluid
去年
Lecanemab Approved in Mexico for Early Alzheimer's Disease Treatment
3年前
European Medicines Agency Accepts Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer’s Disease
去年
Australia's TGA Denies Second Approval Attempt for Eisai's Alzheimer's Drug Leqembi
去年
Eisai Completes FDA Submission for Subcutaneous LEQEMBI Maintenance Dosing in Alzheimer's
去年
Lecanemab Demonstrates Superior Binding to Soluble Amyloid-beta Aggregates Compared to Other Antibodies
2年前
Eisai Seeks FDA Approval for Subcutaneous Lecanemab in Alzheimer's Maintenance Therapy
3年前
Lecanemab Shows Promise in Slowing Cognitive Decline in Early Alzheimer's Disease
去年
Eisai's Tau Antibody Etalanetug Receives FDA Fast Track Designation for Alzheimer's Disease
去年
Eisai Seeks FDA Approval for Subcutaneous Leqembi in Alzheimer's Maintenance
第 1 页,共 173 页
上一页
下一页